Author:
Ip Andrew,Mutebi Alex,Wang Tongsheng,Jun Monika,Kalsekar Anupama,Navarro Fernando Rivas,Wang Anthony,Kamalakar Rajesh,Sacchi Mariana,Elliott Brian
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference46 articles.
1. Lymphoma - non-Hodgkin: Subtypes. 2022 28 Jun 2023]. https://www.cancer.net/cancer-types/lymphoma-non-hodgkin/subtypes. Accessed 28 Jun 2023.
2. Cancer stat facts: NHL — diffuse large b-cell lymphoma (DLBCL). 2023 28 Jun 2023]. https://seer.cancer.gov/statfacts/html/dlbcl.html. Accessed 28 Jun 2023.
3. Chihara D, Johnston K, Bolatova T, et al. An epidemiological model to estimate the prevalence of diffuse large B-cell lymphoma in the United States. Clin Lymphoma Myeloma Leuk. 2022;22:e1092–9.
4. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: B-cell lymphomas v5. 2023 [cited 2023 August 10, 2023]. https://www.nccn.org/professionals/physician_gls/default_nojava.aspx. Accessed August 10, 2023.
5. Crump M, Neelapu SS, Farooq U, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130:1800–8.